Guangzhou, China

Bangxing Wang

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bangxing Wang. Retrieved from https://idiyas.com/inventor/bangxing-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bangxing Wang: Innovator in Tuberculosis Treatment

Introduction

Bangxing Wang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of medicine, particularly in the treatment of tuberculosis. His innovative work has led to the development of a unique pharmaceutical composition aimed at combating this serious health issue.

Latest Patents

Wang holds a patent for the "Construction Method of Recombinant Drug-Resistant Mycobacterium Bovis Bacillus Calmette-Guerin (BCG) Strain and Pharmaceutical Composition for Treating Tuberculosis (TB)." This patent represents a crucial advancement in the fight against tuberculosis, showcasing his dedication to improving public health.

Career Highlights

Bangxing Wang is affiliated with the Chinese Academy of Sciences, where he conducts research and develops innovative solutions for complex medical challenges. His work is characterized by a commitment to scientific excellence and a focus on practical applications that can benefit society.

Collaborations

Wang has collaborated with notable colleagues, including Tianyu Zhang and Julius Ndirangu Mugweru. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Bangxing Wang's contributions to tuberculosis treatment through his innovative patent highlight his role as a key figure in medical research. His work not only addresses a critical health issue but also exemplifies the importance of innovation in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…